Citation Impact
Citing Papers
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia
2003 Standout
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
2009 Standout
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
2011 StandoutNature
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Langerhans'-Cell Histiocytosis (Histiocytosis X) -- A Clonal Proliferative Disease
1994 Standout
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Advances in metal-induced oxidative stress and human disease
2011 Standout
Treatment of acute promyelocytic leukaemia
2001
Regimen-related toxicity in patients undergoing bone marrow transplantation.
1988 StandoutNobel
Phenotypic conversion of T lymphoblastic lymphoma to acute biphenotypic leukemia composed of lymphoblasts and myeloblasts. Molecular genetic evidence of the same clonal origin.
1988 StandoutNobel
Acute and chronic arsenic toxicity
2003 Standout
Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome.
1989
The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia
1992 Standout
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
1991 StandoutNature
All-trans-Retinoic Acid in Acute Promyelocytic Leukemia
1997
The myelodysplastic syndrome.
1989
An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients
2000 Standout
Immunogenotypes of Lymphoid Malignancies; the Rearrangement of T Cell Receptor β Chain Gene Can Occur before the γ Chain Gene Rearrangement
1988 StandoutNobel
Oxidative Stress in Cancer
2020 Standout
ACUTE MYELOID LEUKAEMIA IN THE ELDERLY: BIOLOGY AND TREATMENT
1993
Prognostic value of cytologic parameters in acute myelogenous leukemia
1984
Expression of Functional Markers in Acute Nonlymphoblastic Leukemia
2000
Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors
1994
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission.
1989 StandoutNobel
Disseminated Intravascular Coagulation
1999 Standout
Diagnostic criteria and classification of mastocytosis: a consensus proposal
2001 Standout
Treatment of Myelodysplastic Syndromes with AML-Type Chemotherapy
1993
Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: a Cancer and Leukemia Group B Study.
1996
Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem‐cell glycoprotein CD34 (My 10)
1990
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study.
1997
Biphenotypic leukemia: Immunologic and morphologic evidence for a common lymphoid-myeloid progenitor in humans
1983
United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
2001 Standout
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
2003 Standout
Acute Promyelocytic Leukemia
1993
Acute leukemia with two cell populations of lymphoblasts and monoblasts
1984
Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients [see comments]
1990
Dysmyelopoietic syndromes a search for prognostic factors in 193 patients
2006
Lineage switch in acute leukemia
1984
Bone marrow transplantation for acute nonlymphocytic leukemia in first remission: analysis of prognostic factors
1985
Phenotypic analysis of acute lymphoblastic leukemia (ALL) cells which are classified as non-T non-B and negative for common ALL antigen
1985
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
1997 Standout
A comparison of surface marker analysis and FAB classification in acute myeloid leukemia
1983
Chronic and subacute myelomonocytic leukaemia in the adult: a report of 60 cases with special reference to prognostic factors
1987
Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
1987 StandoutNobel
Bone Marrow Transplantation or Chemotherapy After Remission Induction for Adults with Acute Nonlymphoblastic Leukemia
1984
High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia [see comments]
1992
Bone Marrow Transplant
1990 Standout
Effect of Diagnosis (Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, or Acute Myeloid Leukemia [AML]) on Outcome of AML-Type Chemotherapy
1997
A murine monoclonal antibody specific for a cell-surface antigen expressed by a subgroup of human myeloid leukaemias
1985
COAGULATION DISORDERS IN CANCER
1996
Acute promyelocytic leukemia: from highly fatal to highly curable
2008
Acute myeloblastic leukemia developing in patients with mediastinal lymphoblastic lymphoma
1979
Acute nonlymphoblastic leukemia. Prognostic factors in adults with long-term follow-up
1982
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 Standout
Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia
1995
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia
1991
Clonal evolution in acute myeloid leukemia [editorial; comment]
1993
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Treatment of Therapy-Related Leukemia and Myelodysplastic Syndrome
1993
Expression of p53 in human leukemia and lymphoma
1986
Prognostic value of age and bone marrow karyotype in 78 adults with acute myelogenous leukemia
1982
Proposed Revised Criteria for the Classification of Acute Myeloid Leukemia
1985 Standout
Works of TS Gee being referenced
Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia
1980
Evidence for distinct lymphocytic and monocytic populations in a patient with terminal transferase--positive acute leukemia
1978
Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital
1989
Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia
1980
Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital
1989